Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript
Source: SeekingAlpha
2026-03-19 19:32:21 ET
Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth March 19, 2026 9:00 AM EDT...
Read the full article on Seeking Alpha
For further details see:
Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript
Collegium Pharmaceutical Inc.
NASDAQ: COLL
COLL Trading
-3.18% G/L:
$32.83 Last:
137,423 Volume:
$32.85 Open:
COLL Latest News
March 30, 2026 09:32:05 pm
Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD
COLL Stock Data
$1,476,390,634
30,817,541
0.71%
106
N/A
Pharmaceuticals
Healthcare
US
Stoughton
